• GlaxoSmithKline (GSK) Insists it is the Best Owner for Human Genome Sciences, Inc. (HGSI) More...

• Targacept, Inc. (TRGT) to Cut 46% Of Workforce After Drug-Trial Setbacks More...

• Gene Ray, Founder of $2.6 Billion Titan Corporation (TTN), Invests in MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.)'s ERC Technology and Joins Advisory Board More...

• Vernalis PLC (VNLPY.PK) and Servier Achieve Research Milestone in Drug Discovery Collaboration More...

• AstraZeneca PLC (AZN) and The Medicines Company (MDCO) Announce Global Collaboration in Acute Ischemic Heart Disease More...

• AtheroNova Inc. (AHRO.OB) Signs Agreement for Development of Clinical Trial Supplies More...

• Integral Molecular, Inc. Announces Lipoparticle Distribution in Japan by Funakoshi Co. More...

• Johnson & Johnson (JNJ) CEO Under Fire for Big Bonuses Amid Scandals More...

• Novartis AG (NVS) Tries More Exec Level OTC Switches More...

• Coronado Biosciences Promotes Karin Hehenberger, M.D., Ph.D., to Executive Vice President and Chief Medical Officer More...

• Zyngenia Recruits David Parkinson, M.D., as Board Member, Clinical Advisory Board Head, and Interim Chief Medical Officer More...

• Threshold Pharmaceuticals, Inc. (THLD) Appoints Robert Simon as Senior Vice President of Regulatory Affairs More...

• Boehringer Ingelheim Corporation's 2011 Profit Jumps 66 Percent More...

• Amgen (AMGN) Posts Strong Drug Sales, Beats Estimates More...

• Amgen (AMGN)'s First Quarter 2012 Revenue Increased 9 Percent To $4.0 Billion And Adjusted Earnings Per Share (EPS) Increased 20 Percent To $1.61More...

• Acura Pharmaceuticals, Inc. (ACUR) to Host First Quarter 2012 Financial Results Conference Call on May 2, 2012 More...

• Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) Reports First Quarter 2012 Financial Results and Corporate Updates More...

• ViroPharma Incorporated (VPHM) Loses Bid for Order Blocking Generic Vancocin More...

• Icahn and Amylin Pharmaceuticals, Inc. (AMLN) Have May 10 Hearing for Proxy War More...

• Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc. More...

• Precision BioSciences Files Tenth Patent Infringement Lawsuit Against CELLECTIS SA Related to Meganuclease Technology and Requests Permanent Injunction More...

• Pfizer Consumer Healthcare (PFE) Release: The Advil® Congestion Relief Project Visits St. Louis To Expand Building Space For More Access To Local Family Social Service Program More...

• Ipsen Pursues Its Development in the United States With the Opening of Its New Commercial Headquarters in New Jersey (NJ) More...

• Sanofi (France) (SAN.PA)'s Lemtrada Beats Rebif in MS Face-off More...

• Kythera Biopharmaceuticals Announces Positive Results from Two Pivotal European Phase III Trials of ATX-101 for Reduction of Submental Fat More...

• AVI BioPharma, Inc. (AVII) to Present Additional Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystrophy at the 2012 American Academy of Neurology Annual Meeting More...

• Repligen Corporation (RGEN) Reports Positive Results from Phase 1 Clinical Trial of RG3039 for Spinal Muscular Atrophy More...

• Ablynx Release: Nanobody for Alzheimer's Disease From the Alliance With Boehringer Ingelheim Corporation Moves Closer Towards Phase I Clinical Trials More...

• American Regent, Inc. Initiates Nationwide Voluntary Recall of Epinephrine Injection, USP, 1:1000, 1 mL Ampules Lot #1395 Due to Discoloration and Small Visible Particles More...

• Novartis AG (NVS) Drug SigniforR Gets EU Approval as the First Medication to Treat Patients With Cushing's Disease More...

• Salix Pharmaceuticals, Ltd. (SLXP), Progenics Pharmaceuticals, Inc. (PGNX) Announce FDA Extension of RELISTOR® sNDA Goal Date to July 27, 2012 More...

• Fish Oil Could be Therapy for Periodontal Disease, University of South Australia Reveals More...

• Botox Ingredient Has Limited Effect on Headaches, Medical College of Wisconsin Study More...

• Does Fatty Food Impact Marital Stress? Ohio State University Medical Center Study More...

• Signs of Early DNA "Aging" in Abused Kids, Duke University Study More...

• Evaluating the First Drug to Show Improvement in Subtype of Autism, Mount Sinai School of Medicine Study More...

• VistaGen Therapeutics, Inc. Secures Key U.S. Patent Covering Stem Cell Technology Methods Used to Test Drug Candidates for Liver Toxicity More...

• Lpath, Inc. Receives First U.S. Patent for Anti-LPA Antibody, Lpathomab More...

• Metabolix, Inc. Awarded Two U.S. Patents for Technology to Produce Biobased Polymers and Industrial Chemicals More...

• BioLineRx Ltd. Announces Extension of Patent for BCM (BL-1040) by USPTO More...

• Marshall Edwards, Inc. (MSHL) Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer More...

• Novartis AG (NVS)'s Gilenya Given Final Approval by UK's Cost Agency More...

• PuraMed BioScience Continues to Build Awareness for LipiGesic(R) M Through Media Campaigns More...

• New Products from Abbott Laboratories (ABT)'s EAS(R) Sports Nutrition Brand Help Athletes Improve Post-Workout Recovery and Meet Fitness Goals More...